WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking ...

NEW YORK (Reuters Health) - In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S. as Chantix - were no more prone to depression or ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

Pfizer Inc.’s stop-smoking pill Chantix has been linked to more than 3,000 reports in America of serious side effects, including suicides, heart trouble, and aggression, a study said. American ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. WASHINGTON • Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter ...

(Reuters) - U.S. health regulators on Friday allowed Pfizer Inc to remove a serious warning from the label of its smoking cessation treatment, Chantix, giving a new lease of life to the controversial ...

Kicking the habit can be hard enough, but smokers with depression face a steeper challenge. Now there’s evidence that the drug varenincline (Chantix) can help. About half of smokers who try to quit ...

The Food and Drug Administration has been investigating reports of mood disorders and erratic behavior among Chantix patients since 2007. The agency said in a statement that two federally-funded ...

On Thursday, Pfizer announced the results of a study of the safety and effectiveness of its Chantix smoking-cessation drug on relapsed smokers. The prognosis was good. Over the course of 12 weeks of ...

Pfizer Inc. PFE's Chantix is a prescription medication that helps adults 18 years and older quit smoking. The drug has been linked with reports of mental health problems, risk of suicide, depression ...

WASHINGTON — Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior. The ...